Castle Biosciences gets on board the Sun Bus for another year to boost skin cancer awareness

Castle Biosciences is, for its third consecutive year, backing the Sun Bus during Skin Cancer Awareness Month this May. 

The Texas-based medical technology company, which markets several skin cancer tests, including for melanoma, is continuing its support for the so-called Sun Bus program.

The program was first launched by the Colorado Melanoma Foundation in 2019 and works as a mobile clinic to provide free skin cancer screenings as well as boost skin cancer awareness across nine U.S. states. The Sun Bus tour began in April and will run through November. 

“At our core, we are passionate about transforming disease management, improving health and making a meaningful difference in the lives of those affected by skin cancer,” said Derek Maetzold, president and CEO of Castle Biosciences, in a press release.

“Skin Cancer Awareness Month provides an opportunity to reaffirm our commitment to improving patient care through our partnerships with patient-focused organizations who enable us to broaden our impact on the patient communities we serve and promote the importance of prevention, early detection and optimized treatment.”

Castle is also backing The Skin Cancer Foundation's “key educational programs” as well as the nonprofit's fundraising event in New York City, according to the press release. 

Castle isn’t the only medtech company seeking to help block out the rays as the weather heats up. Earlier this month, genomics testing company DermTech released a new survey finding that most consumers have not had a full skin exam to check for potential skin cancers in the past 12 months.

The company is, in tandem with the survey, handing out pledge stickers to doctors’ offices in the U.S. for patients to make a pledge to get checked and will also be giving out UV bracelets that change color if they deem the wearer has spent too long in the sun.